Michele M. Spence

1.6k total citations · 1 hit paper
24 papers, 1.2k citations indexed

About

Michele M. Spence is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Family Practice. According to data from OpenAlex, Michele M. Spence has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Geriatrics and Gerontology, 7 papers in Economics and Econometrics and 6 papers in Family Practice. Recurrent topics in Michele M. Spence's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Medication Adherence and Compliance (6 papers) and Inflammatory mediators and NSAID effects (4 papers). Michele M. Spence is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Medication Adherence and Compliance (6 papers) and Inflammatory mediators and NSAID effects (4 papers). Michele M. Spence collaborates with scholars based in United States. Michele M. Spence's co-authors include Rita L. Hui, Gerald Levy, David J. Graham, Stanford Shoor, David Campen, Wayne A. Ray, Craig Cheetham, James Chan, Melissa M. Parker and Howard H. Moffet and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Diabetes Care.

In The Last Decade

Michele M. Spence

23 papers receiving 1.1k citations

Hit Papers

Risk of acute myocardial infarction and sudden cardiac de... 2005 2026 2012 2019 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele M. Spence United States 13 472 265 181 160 151 24 1.2k
Federica Nicotra Italy 16 463 1.0× 487 1.8× 163 0.9× 331 2.1× 155 1.0× 21 1.5k
Arja Helin‐Salmivaara Finland 19 368 0.8× 285 1.1× 375 2.1× 382 2.4× 98 0.6× 37 1.4k
Consuelo Huerta Spain 22 423 0.9× 361 1.4× 129 0.7× 553 3.5× 109 0.7× 66 2.3k
Alex Kopp Canada 15 755 1.6× 778 2.9× 115 0.6× 406 2.5× 111 0.7× 27 2.0k
Tom Schalekamp Netherlands 17 258 0.5× 325 1.2× 212 1.2× 101 0.6× 179 1.2× 28 1.7k
Søren Rasmussen Denmark 13 429 0.9× 1.0k 3.8× 142 0.8× 323 2.0× 299 2.0× 27 1.9k
Deborah Layton United Kingdom 24 342 0.7× 203 0.8× 132 0.7× 77 0.5× 28 0.2× 64 1.1k
Caroline Samer Switzerland 28 283 0.6× 406 1.5× 68 0.4× 199 1.2× 152 1.0× 107 2.5k
Rune Dahlqvist Sweden 15 187 0.4× 105 0.4× 98 0.5× 176 1.1× 153 1.0× 27 1.3k
Jens P. Kampmann Denmark 21 304 0.6× 282 1.1× 57 0.3× 145 0.9× 262 1.7× 71 1.5k

Countries citing papers authored by Michele M. Spence

Since Specialization
Citations

This map shows the geographic impact of Michele M. Spence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele M. Spence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele M. Spence more than expected).

Fields of papers citing papers by Michele M. Spence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele M. Spence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele M. Spence. The network helps show where Michele M. Spence may publish in the future.

Co-authorship network of co-authors of Michele M. Spence

This figure shows the co-authorship network connecting the top 25 collaborators of Michele M. Spence. A scholar is included among the top collaborators of Michele M. Spence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele M. Spence. Michele M. Spence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spence, Michele M., et al.. (2020). Risk of Overdose with Exposure to Prescription Opioids, Benzodiazepines, and Non-benzodiazepine Sedative-Hypnotics in Adults: a Retrospective Cohort Study. Journal of General Internal Medicine. 35(3). 696–703. 49 indexed citations
2.
Truong, Thach‐Giao, Fang Niu, Michele M. Spence, et al.. (2018). Immune-related adverse events (IrAE) of elderly patients (pts) receiving PD-1 or PDL-1 inhibitors (PDIs) in a community-oncology setting: The experience at Kaiser Permanente California.. Journal of Clinical Oncology. 36(5_suppl). 124–124. 3 indexed citations
3.
Spence, Michele M., et al.. (2018). Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System. Journal of Managed Care & Specialty Pharmacy. 24(2). 114–122. 43 indexed citations
4.
Spence, Michele M., Rita L. Hui, Jennifer Chang, et al.. (2017). Treatment Patterns and Overall Survival Associated with First-Line Systemic Therapy for Patients with Advanced Non-Small Cell Lung Cancer. Journal of Managed Care & Specialty Pharmacy. 23(2). 195–205. 13 indexed citations
5.
Spence, Michele M., et al.. (2016). The Risk of Pneumonia in Older Adults Using Nonbenzodiazepine Hypnotics. Journal of Managed Care & Specialty Pharmacy. 22(8). 932–938. 10 indexed citations
6.
Hui, Rita L., et al.. (2016). Identifying Subsequent Therapies in Patients with Advanced Non–Small Cell Lung Cancer and Factors Associated with Overall Survival. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(10). 1065–1074. 2 indexed citations
7.
Spence, Michele M., et al.. (2015). Risk of Injury in Older Adults Using Gastrointestinal Antispasmodic and Anticholinergic Medications. Journal of the American Geriatrics Society. 63(6). 1197–1202. 8 indexed citations
8.
Hui, Rita L., et al.. (2014). Impact of a Medicare MTM program: evaluating clinical and economic outcomes.. PubMed. 20(2). e43–51. 25 indexed citations
9.
Spence, Michele M., et al.. (2014). Evaluation of an Outpatient Pharmacy Clinical Services Program on Adherence and Clinical Outcomes Among Patients with Diabetes and/or Coronary Artery Disease. Journal of Managed Care Pharmacy. 20(10). 1036–1045. 49 indexed citations
10.
Spence, Michele M., et al.. (2013). Risk of Injury Associated with Skeletal Muscle Relaxant Use in Older Adults. Annals of Pharmacotherapy. 47(7-8). 993–998. 33 indexed citations
11.
Spence, Michele M., et al.. (2012). Evaluation of Clinical and Safety Outcomes Associated with Conversion from Brand‐Name to Generic Tacrolimus in Transplant Recipients Enrolled in an Integrated Health Care System. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 32(11). 981–987. 34 indexed citations
12.
Spence, Michele M., et al.. (2011). Evaluation of a Pharmacist-Managed Amiodarone Monitoring Program. Journal of Managed Care Pharmacy. 17(7). 513–522. 14 indexed citations
13.
Spence, Michele M., Rita L. Hui, James Chan, & Joanne E. Schottinger. (2010). Risk of Skeletal-Related Events in Patients with Advanced Prostate Cancer Treated with Pamidronate or Zoledronic Acid. Annals of Pharmacotherapy. 44(9). 1384–1388. 5 indexed citations
14.
Karter, Andrew J., Melissa M. Parker, Howard H. Moffet, et al.. (2007). Effect of cost-sharing changes on self-monitoring of blood glucose.. PubMed. 13(7). 408–16. 11 indexed citations
15.
Chan, James, Rita L. Hui, & Michele M. Spence. (2007). Effects on Resource Utilization of Adding Salmeterol in Combination or Separately to Inhaled Corticosteroids. Journal of Managed Care Pharmacy. 13(1). 21–27. 13 indexed citations
16.
Spence, Michele M., Rita L. Hui, & James Chan. (2006). Cost Reduction Strategies Used by Elderly Patients With Chronic Obstructive Pulmonary Disease to Cope With a Generic-Only Pharmacy Benefit. Journal of Managed Care Pharmacy. 12(5). 377–382. 12 indexed citations
17.
Spence, Michele M., Stephanie S. Teleki, T. Craig Cheetham, Stuart O. Schweitzer, & Mirta Millares. (2005). Direct-to-consumer Advertising of COX-2 Inhibitors. Anesthesiology. 73(5). 1057–1057. 2 indexed citations
18.
Graham, David J., David Campen, Rita L. Hui, et al.. (2005). Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. The Lancet. 365(9458). 475–481. 683 indexed citations breakdown →
19.
Spence, Michele M., Stephanie S. Teleki, T. Craig Cheetham, Stuart O. Schweitzer, & Mirta Millares. (2005). Direct-to-Consumer Advertising of COX-2 Inhibitors: Effect on Appropriateness of Prescribing. Medical Care Research and Review. 62(5). 544–559. 47 indexed citations
20.
Cheetham, T. Craig, Gerald Levy, & Michele M. Spence. (2003). Predicting the risk of gastrointestinal bleeding due to nonsteroidal antiinflammatory drugs: NSAID electronic assessment of risk.. PubMed. 30(10). 2241–4. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026